Erlocip 150 mg contains erlotinib 150 mg, a targeted anticancer medicine (EGFR tyrosine kinase inhibitor). It is a prescription-only medication used to treat certain cancers, not a general chemotherapy drug.
It is commonly prescribed for:
Non-small cell lung cancer (NSCLC), particularly in patients whose tumors have specific EGFR mutations.
Pancreatic cancer, usually in combination with other treatments such as gemcitabine.
Important points:
Take it on an empty stomach (at least 1 hour before or 2 hours after food).
Take it exactly as prescribed by your oncologist.
Do not stop or change the dose without medical advice.
Common side effects include:
Skin rash or acne-like rash
Diarrhea
Fatigue
Nausea
Loss of appetite
Mouth sores
Seek urgent medical attention if you develop:
Severe or persistent diarrhea
Sudden worsening cough or shortness of breath
Severe eye pain or vision changes
Signs of liver problems (such as yellowing of the skin or eyes)
If you're asking because you or a family member has been prescribed Erlocip 150 mg, I can also explain:
why it was chosen,
how to take it safely,
expected side effects and how to manage them,
or possible interactions with other medicines.
